Vichinsky E, Hoppe CC, Ataga KI, et al. Results from the randomized placebo-controlled phase 3 HOPE trial of voxelotor in adults and adolescents with sickle cell disease. 24th Congress of EHA, abstract S147.
Integratie palliatieve en transplantatiezorg geeft reductie symptoomlast en angstklachten bij HCT
sep 2017